Xiaobin Cui
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 11
-
- RNA modifications and cancer 12
- Epigenetics and DNA Methylation 10
- Cancer-related gene regulation 9
- Co-authors
- Yunzhao Chen (45 shared papers)Jian Ming Hu (27 shared papers)Chunxia Liu (33 shared papers)Lan Yang (12 shared papers)Hao Peng (6 shared papers)Weihua Liang (15 shared papers)Xueping Han (4 shared papers)Hong Zhou (3 shared papers)
- Journals
- PLoS ONE (4 papers)Human Pathology (3 papers)International Journal of Medical Informatics (2 papers)Journal of Chromatography B (2 papers)Epigenetics (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xiaobin Cui
82 papers receiving 1.6k citations
Xiaobin Cui's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 485
- Molecular Biology 816
- Oncology 242
- Pulmonary and Respiratory Medicine 193
- Pathology and Forensic Medicine 103
Countries citing papers authored by Xiaobin Cui
This map shows the geographic impact of Xiaobin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Cui more than expected).
Fields of papers citing papers by Xiaobin Cui
This network shows the impact of papers produced by Xiaobin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Cui. The network helps show where Xiaobin Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression Hit paper breakdown → | 2019 | 335 |
| 2 | 2017 | 52 | |
| 3 | 2014 | 47 | |
| 4 | 2016 | 44 | |
| 5 | 2018 | 40 | |
| 6 | 2013 | 40 | |
| 7 | 2015 | 39 | |
| 8 | Genetic variation in miR-100 rs1834306 is associated with decreased risk for esophageal squamous cell carcinoma in Kazakh patients in northwest China. | 2015 | 37 |
| 9 | 2017 | 33 | |
| 10 | 2013 | 32 | |
| 11 | 2019 | 32 | |
| 12 | 2015 | 31 | |
| 13 | 2013 | 29 | |
| 14 | 2013 | 29 | |
| 15 | 2018 | 29 | |
| 16 | 2019 | 28 | |
| 17 | 2014 | 27 | |
| 18 | 2020 | 27 | |
| 19 | 2013 | 25 | |
| 20 | 2015 | 23 |
About Xiaobin Cui
Xiaobin Cui is a scholar working on Cancer Research, Molecular Biology, Oncology, Pathology and Forensic Medicine and Surgery, having authored 87 papers that have together received 1.6k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (15 papers), RNA modifications and cancer (12 papers), MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (11 papers), Epigenetics and DNA Methylation (10 papers), Cancer-related gene regulation (9 papers), Sarcoma Diagnosis and Treatment (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Cancer Research (485 citations), Molecular Biology (816 citations), Oncology (242 citations), Pulmonary and Respiratory Medicine (193 citations) and Pathology and Forensic Medicine (103 citations). Xiaobin Cui has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Yunzhao Chen, Jian Ming Hu, Chunxia Liu, Lan Yang, Hao Peng, Weihua Liang, Xueping Han, Hong Zhou, Jie Yu and Dandan Wang. Their work appears in journals such as PLoS ONE, Human Pathology, International Journal of Medical Informatics, Journal of Chromatography B and Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.